As shown, depletion of either CD8+ or CD4+ T cells similarly abolished the therapeutic effects of NDV-GP and led to a significant reduction in long-term survival of MC38 tumor-bearing mice with LCMV memory (Fig. 3b). This evidence concerns the gene CD8A and neoplasm.